Vepsitamab Antibody
Vepsitamab (AMG 199) is a bispecific T-cell engager (BiTE) antibody that targets MUC17 on cancer cells and CD3 on T cells, redirecting T-cell cytotoxicity against tumors. This mechanism supports its investigation in preclinical models for gastrointestinal cancers, facilitating research into targeted immunotherapy in both in vitro and in vivo settings.
Product Specifications
Target
Integrin
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog